We are live on ! Find out more
AMRX icon

Amneal Pharmaceuticals
AMRX

277 hedge funds and large institutions have $1.95B invested in Amneal Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 100 increasing their positions, 80 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

611% more call options, than puts

Call options by funds: $7.01M | Put options by funds: $985K

128% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 25

29% more capital invested

Capital invested by funds: $1.51B → $1.95B (+$437M)

25% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 80

12% more funds holding

Funds holding: 248 → 277 (+29)

1.15% more ownership

Funds ownership: 48.01% → 49.17% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

Holders
277
Holders Change
+29
Holders Change %
+11.69%
% of All Funds
3.37%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
57
Increased
100
Reduced
80
Closed
25
Calls
$7.01M
Puts
$985K
Net Calls
+$6.02M
Net Calls Change
-$921K

Top Buyers

1
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$18.4M
2
Morgan Stanley
Morgan Stanley
New York
+$15M
3
PHS
PFM Health Sciences
California
+$12.7M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$12.5M
5
PCM
Penn Capital Management
Pennsylvania
+$11.5M

Top Sellers

1
NCM
Nantahala Capital Management
Connecticut
-$20.3M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$17.5M
3
Deutsche Bank
Deutsche Bank
Germany
-$9.56M
4
Prudential Financial
Prudential Financial
New Jersey
-$8.48M
5
Walleye Capital
Walleye Capital
New York
-$8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$226M -$540K -47,158 -0.3%
BlackRock
2
BlackRock
New York
$180M +$2.57M +224,867 +2%
RCMNY
3
Rubric Capital Management (New York)
New York
$155M – – –
TGA
4
TPG GP A
Texas
$155M – – –
Citadel Advisors
5
Citadel Advisors
Florida
$77.8M +$5.11M +446,438 +8%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$70.7M +$2.04M +177,906 +3%
Morgan Stanley
7
Morgan Stanley
New York
$60.7M +$15M +1,315,018 +38%
State Street
8
State Street
Massachusetts
$51.8M +$1.56M +136,662 +3%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$50.2M -$550K -48,079 -1%
Assenagon Asset Management
10
Assenagon Asset Management
Luxembourg
$47.4M +$18.4M +1,611,698 +75%
Neuberger Berman Group
11
Neuberger Berman Group
New York
$46.1M -$694K -60,684 -2%
Millennium Management
12
Millennium Management
New York
$42.3M +$314K +27,447 +0.8%
N
13
Nuveen
North Carolina
$40.6M -$40.2K -3,511 -0.1%
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
$33.5M +$12.5M +1,096,643 +70%
Goldman Sachs
15
Goldman Sachs
New York
$32.5M +$1.38M +120,861 +5%
NCM
16
Nantahala Capital Management
Connecticut
$30.8M -$20.3M -1,777,048 -42%
Charles Schwab
17
Charles Schwab
California
$27M +$705K +61,657 +3%
Acadian Asset Management
18
Acadian Asset Management
Massachusetts
$25.5M -$6.51M -569,351 -22%
Invesco
19
Invesco
Georgia
$22.1M +$748K +65,332 +4%
BCP
20
BlackBarn Capital Partners
New York
$19.8M -$7.09M -619,452 -28%
Northern Trust
21
Northern Trust
Illinois
$19.5M -$937K -81,925 -5%
Allspring Global Investments
22
Allspring Global Investments
North Carolina
$18.7M +$3.94M +344,373 +30%
PHS
23
PFM Health Sciences
California
$18.5M +$12.7M +1,109,662 +312%
WW
24
Westshore Wealth
California
$17.4M – – –
Susquehanna International Group
25
Susquehanna International Group
Pennsylvania
$16.7M +$548K +47,892 +4%
1
2 3 4 5

AMRX Hedge Fund Activity: Q4 2025 in Review

277 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Amneal Pharmaceuticals (AMRX) for Q4 2025, worth a combined $1.95B — up 29% from $1.51B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new AMRX positions and 25 closed out — a net gain of 32 holders — while 100 added to existing stakes and 80 trimmed.

The largest buyer was Assenagon Asset Management, adding an estimated $18.4M. The largest seller was Nantahala Capital Management, cutting an estimated $20.3M.

  • 277 institutional investors held Amneal Pharmaceuticals (AMRX) as of Q4 2025, up from 248 in Q3 2025.
  • Funds reported $1.95B of Amneal Pharmaceuticals stock for Q4 2025, up 29% quarter-over-quarter.
  • 57 funds opened new Amneal Pharmaceuticals positions in Q4 2025 and 25 closed out, a net change of +32 holders.
  • The largest Amneal Pharmaceuticals buyer in Q4 2025 was Assenagon Asset Management, an estimated $18.4M added.
  • The largest Amneal Pharmaceuticals seller in Q4 2025 was Nantahala Capital Management, an estimated $20.3M sold.

Based on aggregated 13F filings for Q4 2025.